Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs

Neuropsychiatric disorders are the third leading cause of global disease burden. Current pharmacological treatment for these disorders is inadequate, with often insufficient efficacy and undesirable side effects. One reason for this is that the links between molecular drug action and neurobehavioral...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Commun
Auteurs principaux: Noori, Hamid R., Mervin, Lewis H., Bokharaie, Vahid, Durmus, Özlem, Egenrieder, Lisamon, Fritze, Stefan, Gruhlke, Britta, Reinhardt, Giulia, Schabel, Hans-Hendrik, Staudenmaier, Sabine, Logothetis, Nikos K., Bender, Andreas, Spanagel, Rainer
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224407/
https://ncbi.nlm.nih.gov/pubmed/30410047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-07239-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires